Action - AMLN

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

30,98

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

30,98

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ...

Bristol-Myers Squibb Company (NYSE: BMY) (“Bristol-Myers Squibb”) announced today that the waiting period under the...

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...

Levi & Korsinsky is investigating the Board of Directors of Amylin Pharmaceuticals, Inc. (“Amylin” or the “Company”) (Nasdaq:...

Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...

Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with Its Proposed Merger...

Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

Bristol-Myers Squibb Company (NYSE: BMY) is commencing today, through its wholly owned subsidiary B&R Acquisition Company, a...

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc. PR Newswire DALLAS, July 9...

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Amylin...

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc. PR Newswire BALA CYNWYD, Pa., July 3, 2012 BALA...

Ryan & Maniskas, LLP Announces Investigation of Amylin Pharmaceuticals, Inc.

Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/amln) is investigating potential claims against the board of directors of Amylin...

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...

Levi & Korsinsky is investigating the Board of Directors of Amylin Pharmaceuticals, Inc. (“Amylin” or the “Company”) (Nasdaq:...

Harwood Feffer LLP Announces Investigation of Amylin Pharmaceuticals, Inc.

Harwood Feffer LLP Announces Investigation of Amylin Pharmaceuticals, Inc. PR Newswire NEW YORK, July 2, 2012 NEW YORK, July 2, 2012 /PRNewswire/...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

AMLN - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 30,98

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MASS908 Devices Inc	US$ 3,39 (71,21%)	89,75M
FRGTFreight Technologies Inc	US$ 1,555 (50,97%)	62,39M
PTIXProtagenic Therapeutics Inc	US$ 0,3908 (41,44%)	60,01M
JFINJiayin Group Inc	US$ 9,45 (33,66%)	626,72k
MULNMullen Automotive Inc	US$ 2,639 (28,11%)	2,41M
TNYATenaya Therapeutics Inc	US$ 0,4601 (-51,41%)	8,86M
AGHAureus Greenway Holdings Inc	US$ 1,1041 (-49,12%)	1,17M
STISolidion Technology Inc	US$ 0,1665 (-44,74%)	6,26M
JRVRJames River Group Holdings Ltd	US$ 3,25 (-33,67%)	1,42M
STBXStarBox Group Holdings Ltd	US$ 0,5999 (-32,60%)	417,25k
NVDANVIDIA Corporation	US$ 114,7925 (0,64%)	195,76M
UOKAMDJM Ltd	US$ 0,1794 (19,60%)	114,56M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 11,19 (-11,68%)	111,98M
BTOGBit Origin Ltd	US$ 0,381 (19,32%)	109,34M
MASS908 Devices Inc	US$ 3,3801 (70,71%)	88,67M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amylin Pharmaceuticals, Inc. (MM) (AMLN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

AMLN Dernières nouvelles

Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ...

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...

Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...

Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.

Ryan & Maniskas, LLP Announces Investigation of Amylin Pharmaceuticals, Inc.

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...

Harwood Feffer LLP Announces Investigation of Amylin Pharmaceuticals, Inc.

AMLN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amylin Pharmaceuticals, Inc. (MM) (AMLN) Cours

Amylin Pharmaceuticals, Inc. (MM) (AMLN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

AMLN Dernières nouvelles

Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ...

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...

Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...

Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.

Ryan & Maniskas, LLP Announces Investigation of Amylin Pharmaceuticals, Inc.

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...

Harwood Feffer LLP Announces Investigation of Amylin Pharmaceuticals, Inc.

AMLN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS